Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer

RecruitingOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

March 7, 2024

Primary Completion Date

March 7, 2029

Study Completion Date

March 7, 2029

Conditions
Head and Neck Tumors
Interventions
BIOLOGICAL

Culture of organoids

Culture of organoids prepared from both the primary tumor and the respective relapse, using the material from the prospective part of the study, the response to treatment will be carried out by macroscopic analysis, evaluating the size and number of organoids before and after treatment,

Trial Locations (1)

00144

RECRUITING

IRCCS National Cancer institute, Roma

All Listed Sponsors
lead

Regina Elena Cancer Institute

OTHER